Most Americans now take medications to treat chronic health conditions

25 May 2008

Americans have tipped the scale in terms of medicines consumption. For the first time, a majority of the insured population is being treated for a chronic medical condition, which is raising serious concerns about the health of the nation.

Research released by leading pharmacy benefit management firm Medco Health Solutions, shows that, in 2007, 51% of insured American people were taking prescription drugs to treat at least one chronic health problem. Not only is it now a majority, but many of these patients are on multiple medications. According to the analysis, one fifth of the population used three or more of these chronic drug treatments last year.

"It appears that we have now reached the tipping point where treating chronic diseases and conditions is more common than not," said Robert Epstein, Medco's chief medical officer. "This data does paint a pretty unhealthy picture of America. But there is a silver lining; it does show that people are receiving treatment which can prevent more serious health problems down the road," Dr Epstein added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight